Shilpa Medicare Limited, Unit VI, Bengaluru facility has been issued UK MHRA GMP

Shilpa Medicare Limited's newly commissioned facility for manufacture and testing of Orodispersible films and Transdermal systems situated at Dabaspet, Bengaluru, Karnataka State, has been issued GMP Certificate by UK MHRA. The facility was inspected by MHRA from 18 Apr 2022 to 20 Apr 2022.

The facility is involved in manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems. The facility is backed up with strong Research and Development of Orodispersible films and transdermal technologies. The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 398.10 as compared to the previous close of Rs. 399.60. The total number of shares traded during the day was 4272 in over 533 trades.

The stock hit an intraday high of Rs. 404.70 and intraday low of 393.30. The net turnover during the day was Rs. 1708038.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 OrodispersibleFIlms TransdermalSystems UKMHRA GMPCertificate